| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, CFO And Treasurer
1 company
Spellman David A is a SVP, CFO And Treasurer at Akebia Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $518K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2023 | AKBA Akebia Therapeutics, Inc. | SVP, CFO And Treasurer | Sell | 63,567 | $1.07 | $67,889.56 | -12.5% | +25.7% | +12.4% | |
| Mar 1, 2023 | AKBA Akebia Therapeutics, Inc. | SVP, CFO And Treasurer | Sell | 7,210 | $0.88 | $6,326.78 | -0.7% | +4.8% | +72.7% | |
| Feb 27, 2023 | AKBA Akebia Therapeutics, Inc. | SVP, CFO And Treasurer | Sell | 7,539 | $0.81 | $6,130.71 | -1.4% | +17.5% | +101.1% | |
| Mar 1, 2022 | AKBA Akebia Therapeutics, Inc. | SVP, CFO And Treasurer | Sell | 8,203 | $2.16 | $17,688.59 | -4.0% | -82.8% | -57.4% | |
| Apr 1, 2021 | AKBA Akebia Therapeutics, Inc. | SVP, CFO And Treasurer | Sell | 790 | $3.40 | $2,686.00 | -1.0% | +13.8% | -79.9% |